Volume 6 Issue 2
Mar.  2015
Turn off MathJax
Article Contents
Pei Xiangke, Jiang Wei, Liu Yanbin, et al. Observation on safety of renal transplantation in patients with idiopathic thrombocytopenic purpura[J]. ORGAN TRANSPLANTATION, 2015, 6(2): 102-104, 115. doi: 10.3969/j.issn.1674-7445.2015.02.007
Citation: Pei Xiangke, Jiang Wei, Liu Yanbin, et al. Observation on safety of renal transplantation in patients with idiopathic thrombocytopenic purpura[J]. ORGAN TRANSPLANTATION, 2015, 6(2): 102-104, 115. doi: 10.3969/j.issn.1674-7445.2015.02.007

Observation on safety of renal transplantation in patients with idiopathic thrombocytopenic purpura

doi: 10.3969/j.issn.1674-7445.2015.02.007
More Information
  • Corresponding author: Pei Xiangke, E-mail:pxkmail@126.com
  • Received Date: 2014-12-23
  • Publish Date: 2015-03-01
  •   Objective  To investigate the safety of renal transplantation in patients with idiopathic thrombocytopenic purpura (ITP).  Methods  Clinical data of two ITP patients undergoing renal transplantation were retrospectively analyzed and pertinent literatures were reviewed.  Results  Prior to renal transplantation, the platelet count of these two patients was 41×109/L and 34×109/L, respectively. The coagulation function was normal and no active bleeding was observed. They underwent renal transplantation successfully without obvious bleeding intra-or post-operatively. The platelet count of one patient who received hydrocortisone impulse therapy for three days and maintenance treatment with immunosuppressant based on ciclosporin recovered to normal range and kept stable at 7 days after renal transplantation. Though receiving platelet-promoting drugs and platelet infusion, the platelet count of the other patient treated with methylprednisolone impulse therapy for 3 days and maintenance therapy with immunosuppressant based on tacrolimus did not recover to normal range but fluctuated between 10×109/L and 30×109/L after renal transplantation. Renal function was well maintained in both recipients.  Conclusions  The risk of renal transplantation related bleeding in ITP patients is correlated with whether the preoperative active bleeding or not. Renal transplantation is relatively safe for uremia patients without active bleeding pre-operation.

     

  • loading
  • [1]
    Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood, 2010, 115(2):168-186. doi: 10.1182/blood-2009-06-225565
    [2]
    侯明.成人特发性血小板减少性紫癜诊断治疗专家共识[J].中华血液学杂志, 2009, 30(9):647-648. http://d.wanfangdata.com.cn/Periodical/zhxyx200909020

    Hou M. Expert consensus on the diagnosis and treatment of adult idiopathic thrombocytopenic purpura[J]. Chin J Hematol, 2009, 30(9):647-648. http://d.wanfangdata.com.cn/Periodical/zhxyx200909020
    [3]
    Gómez-Almaguer D, Tarín-Arzaga L, Moreno-Jaime B, et al. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia[J]. Eur J Haematol, 2013, 90(6):494-500. doi: 10.1111/ejh.2013.90.issue-6
    [4]
    Colović M, Suvajdzic N, Colović N, et al. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults[J]. Platelets, 2011, 22(2):153-156. doi: 10.3109/09537104.2010.520372
    [5]
    Li J, Wang Z, Dai L, et al. Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia[J]. Clin Dev Immunol, 2013:548085. https://www.hindawi.com/journals/jir/2013/548085/
    [6]
    计成阜, 何广胜, 周海侠, 等.重组人血小板生成素联合环孢素A治疗难治性血小板减少症16例[J].实用医学杂志, 2013, 29(22):3789-3790. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201322075.htm

    Ji CF, He GS, Zhou HX, et al. Recombinant human platelet thrombopoietin combined with ciclosporrin on treatment of intractable thrombocytopenia in 16 cases[J]. J Prac Med, 2013, 29(22):3789-3790. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201322075.htm
    [7]
    Emilia G, Morsetli M, Luppi M, et al. Long-term salvage therapy with cyclosporine A in refractory idiopathic thrombocytopenic purpura[J]. Blood, 2002, 99(4):1482-1485. doi: 10.1182/blood.V99.4.1482
    [8]
    Cui ZG, Liu XG, Qin P, et al. Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia[J].Chin Med J, 2013, 126(21):4145-4148. http://www.researchgate.net/publication/258526016_Recombinant_human_thrombopoietin_in_combination_with_cyclosporin_A_as_a_novel_therapy_in_corticosteroid-resistant_primary_immune_thrombocytopenia
    [9]
    Gergis U, Ibrahim M, Al-Kazaz M, et al. Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation[J]. J Clin Oncol, 2012, 30(26):e241-e242. doi: 10.1200/JCO.2011.40.0499
    [10]
    Wakana K, Yasugi T, Nako Y, et al. Successful surgical treatment and chemotherapy for ovarian cancer in a patient with idiopathic thrombocytopenic purpura[J]. Int J Clin Oncol, 2011, 16(4):447-449. doi: 10.1007/s10147-010-0149-3
    [11]
    Nakajima T, Iyoda A, Iizasa T, et al. Surgical treatment of a superior sulcus tumor in a patient with idiopathic thrombocytopenic purpura:report of a case[J]. Surg Today, 2005, 35(12):1078-1080. doi: 10.1007/s00595-005-3069-5
    [12]
    Kubota Y, Horie K, Nagai S, et al. Laparoscopic left partial nephrectomy for renal cell carcinoma associated with ITP with platelet count of 10, 000/μL[J]. Hinyokika Kiyo(日文), 2013, 59(12):785-789.
    [13]
    Kanodia KV, Vanikar AV, Shah PR, et al. Renal transplantation in idiopathic thrombocytopenic purpura[J]. Saudi J Kidney Dis Transpl, 2013, 24(4):793-794. doi: 10.4103/1319-2442.113890
    [14]
    Einollahi B. Renal transplantation and idiopathic thrombocytopenic purpura:two case reports[J]. Transplant Proc, 2009, 41(7):2923. doi: 10.1016/j.transproceed.2009.07.010
    [15]
    Hwang EM, Woo HY, Choi BS, et al. Renal transplantation in a patient with idiopathic thrombocytopenic purpura[J]. Korean J Intern Med, 2005, 20(1):92-95. doi: 10.3904/kjim.2005.20.1.92
    [16]
    Kojouri K, Vesely SK, Terrell DR, et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura:a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications[J]. Blood, 2004, 104(9):2623-2634. doi: 10.1182/blood-2004-03-1168
    [17]
    Ferndale L, Naidoo M, Bhaila SH, et al. Laparoscopic splenectomy for immune thrombocytopenic purpura[J]. S Afr J Surg, 2013, 51(2):54-56. doi: 10.7196/sajs.1325
    [18]
    Qu Y, Xu J, Jiao C, et al. Long-term outcomes of laparoscopic splenectomy versus open splenectomy for idiopathic thrombocytopenic purpura[J]. Int Surg, 2014, 99(3):286-290. doi: 10.9738/INTSURG-D-13-00175.1
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (117) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return